The numbers of tumor-infiltrating CD26+CD64+MAR-1- cDC2 and CD26+CD64+MAR-1+ inf-cDC2 [24] were instead very low and similar between LLC-Mock and LLC-SULT2B1b (Fig. 2F, G). The gene discussed is FCGR1A; the disease is neoplasm.